Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Amgen, a $14.6 billion biotechnology company in Thousand Oaks, Calif., hired Jonathan Peacock as CFO and executive vice president. He succeeds Robert Bradway, who was promoted to president and chief operating officer in June; Michael Kelly had served as acting CFO. Peacock, 52, had been CFO and administration officer of Novartis Pharmaceutical since 2005. Earlier, he was a partner and co-leader of the corporate finance practice at McKinsey & Co.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.